Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.
about
Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapyThe Landscape of Pancreatic Cancer Therapeutic Resistance MechanismsInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisProgress toward overcoming hypoxia-induced resistance to solid tumor therapyGastric cancer stem cells: a novel therapeutic targetMolecular mechanisms of chemoresistance in gastric cancerHypoxia-induced modulation of apoptosis and BCL-2 family proteins in different cancer cell typesHypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1AlphaTFPI1 mediates resistance to doxorubicin in breast cancer cells by inducing a hypoxic-like responseTargeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells.Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaBHIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.Calcium prevents tumorigenesis in a mouse model of colorectal cancerSe-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells.NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment.Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.PIK3CA and PIK3CB expression and relationship with multidrug resistance in colorectal carcinoma.Effects of hypoxia on human cancer cell line chemosensitivity.Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxiaElevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells.Thyroid hormone and P-glycoprotein in tumor cells.Deficiency of Prdx6 in lens epithelial cells induces ER stress response-mediated impaired homeostasis and apoptosis.miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1Krüppel-like factor 8 contributes to hypoxia-induced MDR in gastric cancer cells.Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer.Predicting chemosensitivity in osteosarcoma prior to chemotherapy: An investigational study of biomarkers with immunohistochemistry.Metabolic stress in autophagy and cell death pathwaysThe potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilizationValproic acid overcomes hypoxia-induced resistance to apoptosis.Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-κB regulation.Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells.Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal CancerRole of the tumor microenvironment in the pathogenesis of gastric carcinoma.Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
P2860
Q26749391-7119A622-29CC-4E19-BE69-DFD62412E34FQ26765247-BF0E345D-D017-484B-B4EA-314C6F30A074Q26767150-A8E93DC3-DFB8-4472-AA2E-2A75DB956C0FQ26796405-36503AC5-262D-42C4-893E-22DD929B3EA8Q27002840-A7CBF7F2-8A5C-4C47-B82A-926CF2B53EC2Q28069259-9B417008-2540-45DC-9720-0772A7EA4367Q28484877-81EE38DB-2EFE-4529-B320-C7B16330BAC9Q28533909-2A4ABF57-6BEB-4655-90AD-6E6B0A7C7445Q28539226-046B64DC-70DB-41FF-8BD5-53DB3668E1F5Q33576827-1D500D4A-F2FB-48B9-9A72-AE87800E2B33Q33656653-C142D334-2BEC-446A-9372-E575CC235987Q33717131-3A9A3EA2-F9AB-4ACA-965D-8DD8C2E1778DQ33998926-1C3F1AF9-BDA5-49AA-818A-B44548679A3DQ34047866-0D2E78EE-0D13-4389-A31E-382804E89290Q34152742-789DFF5F-74FC-446A-8765-16C6E434BD03Q34377146-BA2A2647-4458-4483-A4B6-B1433E2F4A42Q34402422-7B5539B8-0E3B-48B7-99C0-630F1D62D3D9Q34551161-AD789E8F-687F-4F9C-8F81-A7446578FDDEQ34732954-72DD4FB6-BEE3-4B3E-98D0-8A64A5CC9E39Q34799788-DE605B3D-1D2C-4AFC-BBF1-1B3E01BF2D2CQ34992476-20FA7B23-2BE7-4DE0-BE83-B1CA3C43B2DBQ35079142-845BEA1D-5F6B-4923-A16F-4B7DBC2CB791Q35164344-2EB52B04-8B39-4388-94EF-D5CACA0F0C51Q35250590-7453AA16-69E9-4772-8C58-4B3B81F747E8Q35321980-E297A8C7-0E45-48A8-961D-6F49EFE2EE59Q35494926-15D68670-FC87-4E34-9D2F-7EAD4DA0F72CQ35713698-C90ED96A-6883-472E-9EBF-1DBD75049A56Q35915363-276A8243-7669-4121-9F5B-364CA2D8EAA5Q36075947-31B2D644-F4C3-42BC-9F41-ECAA1347B814Q36192905-C1840493-279E-410A-B785-7BEA65619739Q36214152-BFC0D64B-B66B-4854-A1FE-170A443738D6Q36220497-42E4C7C0-693C-4CE2-9CDF-95D865E211DFQ36293304-61A7A774-E3F4-4CCD-83B2-635BE0A40C3CQ36642574-BC5534C0-5FFD-44C3-BA2F-4B9CF24871E9Q36763853-4BF89429-7413-4293-8F97-4FD2F72222DFQ37092712-22DA6A9D-1F4E-421D-B489-5951014B8287Q37146401-7B3DDC7D-C1A0-439F-8972-86618F28A842Q37550889-59C608B3-8A6C-4F8C-97B5-71086E036174Q37596178-00D81808-30A1-4321-871E-63AFFBCA5048Q38097867-89AB9234-6E6C-4629-B3B7-9A7A43AC8F94
P2860
Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hypoxia-inducible factor-1 alp ...... oresistance in gastric cancer.
@en
type
label
Hypoxia-inducible factor-1 alp ...... oresistance in gastric cancer.
@en
prefLabel
Hypoxia-inducible factor-1 alp ...... oresistance in gastric cancer.
@en
P2093
P2860
P1433
P1476
Hypoxia-inducible factor-1 alp ...... oresistance in gastric cancer.
@en
P2093
Changcun Guo
Daiming Fan
Hongbo Zhang
Kaichun Wu
Shiren Sun
Shuang Han
Xiaoxuan Ning
P2860
P304
P356
10.1111/J.1349-7006.2008.00922.X
P577
2007-10-22T00:00:00Z